Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms

Michal P. Wandel, Bae Hoon Kim, Eui Soon Park, Keith B. Boyle, Komal Nayak, Brice Lagrange, Adrian Herod, Thomas Henry, Matthias Zilbauer, John Rohde, John D. MacMicking, Felix Randow

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

198 Citas (Scopus)

Resumen

Bacterial lipopolysaccharide triggers human caspase-4 (murine caspase-11) to cleave gasdermin-D and induce pyroptotic cell death. How lipopolysaccharide sequestered in the membranes of cytosol-invading bacteria activates caspases remains unknown. Here we show that in interferon-γ-stimulated cells guanylate-binding proteins (GBPs) assemble on the surface of Gram-negative bacteria into polyvalent signaling platforms required for activation of caspase-4. Caspase-4 activation is hierarchically controlled by GBPs; GBP1 initiates platform assembly, GBP2 and GBP4 control caspase-4 recruitment, and GBP3 governs caspase-4 activation. In response to cytosol-invading bacteria, activation of caspase-4 through the GBP platform is essential to induce gasdermin-D-dependent pyroptosis and processing of interleukin-18, thereby destroying the replicative niche for intracellular bacteria and alerting neighboring cells, respectively. Caspase-11 and GBPs epistatically protect mice against lethal bacterial challenge. Multiple antagonists of the pathway encoded by Shigella flexneri, a cytosol-adapted bacterium, provide compelling evolutionary evidence for the importance of the GBP–caspase-4 pathway in antibacterial defense.

Idioma originalEnglish
Páginas (desde-hasta)880-891
Número de páginas12
PublicaciónNature Immunology
Volumen21
N.º8
DOI
EstadoPublished - ago. 1 2020

Nota bibliográfica

Funding Information:
We thank J. Kendrick-Jones (MRC Laboratory of Molecular Biology, Cambridge) for providing antiserum against NDP52. This work was supported by the MRC (grant no. U105170648) and the Wellcome Trust (grant no. WT104752MA) to F.R., and by the NIH National Institutes of Allergy and Infectious Diseases (grant nos. R01AI068041-13 and R01AI108834-05) to J.D.M. J.D.M. is an investigator of the Howard Hughes Medical Institute.

Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology

Huella

Profundice en los temas de investigación de 'Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms'. En conjunto forman una huella única.

Citar esto